Takeda Pharmaceutical Co., Ltd. (TKPHF)
37.88
+1.44
(+3.96%)
USD |
OTCM |
Aug 25, 16:00
Takeda Pharmaceutical Net Income (Quarterly) : 710.72M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 710.72M |
| March 31, 2026 | -2.348B |
| December 31, 2025 | 673.28M |
| September 30, 2025 | -79.56M |
| June 30, 2025 | 859.65M |
| March 31, 2025 | -676.47M |
| December 31, 2024 | 156.42M |
| September 30, 2024 | 617.19M |
| June 30, 2024 | 611.56M |
| March 31, 2024 | -20.16M |
| December 31, 2023 | 715.05M |
| September 30, 2023 | -331.84M |
| June 30, 2023 | 650.07M |
| March 31, 2023 | 235.16M |
| December 31, 2022 | 842.54M |
| September 30, 2022 | 446.26M |
| June 30, 2022 | 808.86M |
| March 31, 2022 | -97.80M |
| December 31, 2021 | 508.42M |
| September 30, 2021 | 417.80M |
| June 30, 2021 | 1.259B |
| March 31, 2021 | 1.858B |
| December 31, 2020 | 884.69M |
| September 30, 2020 | 38.35M |
| June 30, 2020 | 767.43M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.68M |
| December 31, 2019 | -295.34M |
| September 30, 2019 | 631.66M |
| June 30, 2019 | 63.97M |
| March 31, 2019 | -265.76M |
| December 31, 2018 | 335.76M |
| September 30, 2018 | 434.26M |
| June 30, 2018 | 715.28M |
| March 31, 2018 | -498.44M |
| December 31, 2017 | 602.52M |
| September 30, 2017 | 249.46M |
| June 30, 2017 | 1.305B |
| March 31, 2017 | -462.50M |
| December 31, 2016 | 387.44M |
| September 30, 2016 | 246.83M |
| June 30, 2016 | 929.84M |
| March 31, 2016 | -285.55M |
| December 31, 2015 | 497.19M |
| September 30, 2015 | 250.13M |
| June 30, 2015 | 209.43M |
| March 31, 2015 | -1.891B |
| December 31, 2014 | 167.69M |
| September 30, 2014 | 277.40M |
| June 30, 2014 | 336.05M |
| March 31, 2014 | -206.18M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Daiichi Sankyo Co., Ltd. | 430.72M |
| Eisai Co., Ltd. | 120.18M |
| Chugai Pharmaceutical Co., Ltd. | 730.02M |
| Santen Pharmaceutical Co., Ltd. | 45.18M |
| Ono Pharmaceutical Co., Ltd. | 151.63M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 7.655B |
| Total Expenses (Quarterly) | 6.945B |
| EPS Diluted (Quarterly) | 0.4427 |
| Enterprise Value | 87.43B |
| Gross Profit Margin (Quarterly) | 57.57% |
| Profit Margin (Quarterly) | 9.28% |
| Earnings Yield | -1.78% |
| Operating Earnings Yield | 7.58% |
| Normalized Earnings Yield | -0.9472 |